본문 바로가기
KERD
논문KCI 등재

Recent Advances in Noncardiac Chest Pain in Korea

김정환|이풍렬
거트앤리버 소화기연관학회협의회|2012.01|Gut and Liver|제6권 제1호|pp. 1-9

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

SerotoninProton pump inhibitorUpper endoscopyNoncardiac chest painGastroesophageal refl ux disease

초록

Gastroesophageal reflux disease (GERD) is the most common cause of noncardiac chest pain (NCCP) and is present in up to 60% of patients with NCCP in Western countries. In Korea, after a reasonable cardiac evaluation, GERD is reported to underlie 41% of NCCP cases. Typical refl ux symptoms are frequent in Korean patients suffering from NCCP. Therefore, a careful history of the predominant symptoms,including heartburn and acid regurgitation, is relatively indicative of the GERD diagnosis in Korea. In Korea, in contrast to Western countries, patients aged 40 years and over who have been diagnosed with NCCP but who are without alarming features should undergo endoscopy to exclude gastric cancer or peptic ulcers because of the higher prevalence of peptic ulcer disease and gastric cancers in the region. In a primary care setting, in the absence of any alarming symptoms,a symptomatic response to a trial of a proton pump inhibitor (PPI) is sufficient for the presumptive diagnosis of GERD. In addition, the optimal duration of a PPI test may be at least 2 weeks, as GERD symptoms tend to be less frequent or atypical in Korean patients than in patients from Western countries. In patients diagnosed with GERD-related NCCP, long-term therapy (more than 2 months) with double the standard dose of a PPI is required to alleviate symptoms. Esophageal dysmotility is relatively uncommon, and pain modulators seem to offer significant improvement of chest pain control in non-GERD-related NCCP. Most traditionally available tricyclics or heterocyclics have many undesirable effects. Therefore, newer drugs with fewer side effects (for example, the serotonin - norepinephrine reuptake inhibitors)may be needed.

Abstract

Gastroesophageal reflux disease (GERD) is the most common cause of noncardiac chest pain (NCCP) and is present in up to 60% of patients with NCCP in Western countries. In Korea, after a reasonable cardiac evaluation, GERD is reported to underlie 41% of NCCP cases. Typical refl ux symptoms are frequent in Korean patients suffering from NCCP. Therefore, a careful history of the predominant symptoms,including heartburn and acid regurgitation, is relatively indicative of the GERD diagnosis in Korea. In Korea, in contrast to Western countries, patients aged 40 years and over who have been diagnosed with NCCP but who are without alarming features should undergo endoscopy to exclude gastric cancer or peptic ulcers because of the higher prevalence of peptic ulcer disease and gastric cancers in the region. In a primary care setting, in the absence of any alarming symptoms,a symptomatic response to a trial of a proton pump inhibitor (PPI) is sufficient for the presumptive diagnosis of GERD. In addition, the optimal duration of a PPI test may be at least 2 weeks, as GERD symptoms tend to be less frequent or atypical in Korean patients than in patients from Western countries. In patients diagnosed with GERD-related NCCP, long-term therapy (more than 2 months) with double the standard dose of a PPI is required to alleviate symptoms. Esophageal dysmotility is relatively uncommon, and pain modulators seem to offer significant improvement of chest pain control in non-GERD-related NCCP. Most traditionally available tricyclics or heterocyclics have many undesirable effects. Therefore, newer drugs with fewer side effects (for example, the serotonin - norepinephrine reuptake inhibitors)may be needed.

참고문헌 (61)

  1. Faybush EM, "Gastroesophageal reflux disease in noncardiac chest pain", Gastroenterol Clin North Am, 33, pp.41~54 (2004)
  2. Eslick GD, "Noncardiac chest pain: evaluation and treatment", Gastroenterol Clin North Am, 32, pp.531~552 (2003)
  3. Eslick GD, "Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study", Aliment Pharmacol Ther, 17, pp.1115~1124 (2003)
  4. Locke GR 3rd, "Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota", Gastroenterology, 112, pp.1448~1456 (1997)
  5. Chambers J, "Chest pain with normal coronary anatomy: a review of natural history and possible etiologic factors", Prog Cardiovasc Dis, 33, pp.161~184 (1990)
  6. Eslick GD, "Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities", Aliment Pharmacol Ther, 20, pp.909~915 (2004)
  7. Achem SR, "Recent developments in chest pain of undetermined origin", Curr Gastroenterol Rep, 2, pp.201~209 (2000)
  8. Van Handel D, "The pathophysiology of non-cardiac chest pain", J Gastroenterol Hepatol, 20(Suppl), pp.S6~S13 (2005)
  9. Nevens F, "Prospective study on prevalence of esophageal chest pain in patients referred on an elective basis to a cardiac unit for suspected myocardial ischemia", Dig Dis Sci, 36, pp.229~235 (1991)
  10. Graves EJ, "Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995", Vital Health Stat 13, (130), pp.1~146 (1997)
  11. Pandak WM, "Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring", J Clin Gastroenterol, 35, pp.307~314 (2002)
  12. Wong WM, "Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain", Aliment Pharmacol Ther, 16, pp.465~471 (2002)
  13. Richter JE, "Chest pain and gastroesophageal reflux disease", J Clin Gastroenterol, 30(3 Suppl), pp.S39~S41 (2000)
  14. Kim JH, "Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea", J Gastroenterol Hepatol, 22, pp.320~325 (2007)
  15. Eslick GD, "Noncardiac chest pain: epidemiology, natural history, health care seeking, and quality of life", Gastroenterol Clin North Am, 33, pp.1~23 (2004)
  16. Tae Ho Seo, "Clinical Distinct Features of Noncardiac Chest Pain in Young Patients", Journal of Neurogastroenterology and Motility (JNM), 16(2), pp.166~171 (2010), 대한소화기 기능성질환∙운동학회
  17. Fass R, "The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain", Gastroenterology, 115, pp.42~49 (1998)
  18. Goh KL, "Gastrooesophageal reflux disease in Asia", J Gastroenterol Hepatol, 15, pp.230~238 (2000)
  19. Cremonini F, "Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis", Am J Gastroenterol, 100, pp.1226~1232 (2005)
  20. Eslick GD, "Usefulness of chest pain character and location as diagnostic indicators of an acute coronary syndrome", Am J Cardiol, 95, pp.1228~1231 (2005)
  21. García-Compeán D, "Prevalence of gastroesophageal reflux disease in patients with extraesophageal symptoms referred from otolaryngology, allergy, and cardiology practices: a prospective study", Dig Dis, 18, pp.178~182 (2000)
  22. Cherian P, "Esophageal tests in the evaluation of non-cardiac chest pain", Dis Esophagus, 8, pp.129~133 (1995)
  23. Hsia PC, "Utility of upper endoscopy in the evaluation of noncardiac chest pain", Gastrointest Endosc, 37, pp.22~26 (1991)
  24. Battaglia E, "Noncardiac chest pain of esophageal origin in patients with and without coronary artery disease", Hepatogastroenterology, 52, pp.792~795 (2005)
  25. Bautista J, "The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain: a randomized, doubleblind, placebo-controlled, crossover trial", Aliment Pharmacol Ther, 19, pp.1123~1130 (2004)
  26. Frøbert O, "Upper endoscopy in patients with angina and normal coronary angiograms", Endoscopy, 27, pp.365~370 (1995)
  27. Dickman R, "Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database", Am J Gastroenterol, 102, pp.1173~1179 (2007)
  28. Kapoor N, "Predictive value of alarm features in a rapid access upper gastrointestinal cancer service", Gut, 54, pp.40~45 (2005)
  29. Sung JJ, "Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies", Gastrointest Endosc, 54, pp.454~458 (2001)
  30. Katz PO, "Diagnosis and therapy of noncardiac chest pain: a clinical dilemma", J Clin Gastroenterol, 35, pp.292~294 (2002)
  31. Wang WH, "Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis", Arch Intern Med, 165, pp.1222~1228 (2005)
  32. Wong WM, "Use of proton pump inhibitor as a diagnostic test in NCCP", J Gastroenterol Hepatol, 20(Suppl), pp.S14~S17 (2005)
  33. Numans ME, "Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics", Ann Intern Med, 140, pp.518~527 (2004)
  34. Bruley des Varannes S, "The proton-pump inhibitor test: pros and cons", Eur J Gastroenterol Hepatol, 16, pp.847~852 (2004)
  35. Bruley des Varannes S, "Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers", Aliment Pharmacol Ther, 8, pp.309~314 (1994)
  36. Vaezi MF, "Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association", Clin Gastroenterol Hepatol, 1, pp.333~344 (2003)
  37. Dickman R, "The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebocontrolled, crossover trial", Aliment Pharmacol Ther, 22, pp.547~555 (2005)
  38. Wong WM, "Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study", Aliment Pharmacol Ther, 18, pp.595~604 (2003)
  39. Wong WM, "Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization", World J Gastroenterol, 10, pp.707~712 (2004)
  40. Kim JH, "Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients", J Gastroenterol Hepatol, 24, pp.1504~1509 (2009)
  41. Kahrilas PJ, "American Gastroenterological Association technical review on the clinical use of esophageal manometry", Gastroenterology, 107, pp.1865~1884 (1994)
  42. Arora AS, "How do I handle the patient with noncardiac chest pain?", Clin Gastroenterol Hepatol, 9, pp.295~304 (2011)
  43. Dekel R, "Evaluation of symptom index in identifying gastroesophageal reflux diseaserelated noncardiac chest pain", J Clin Gastroenterol, 38, pp.24~29 (2004)
  44. Beedassy A, "Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain", J Clin Gastroenterol, 31, pp.121~124 (2000)
  45. Kusano M, "Interobserver and intraobserver variation in endoscopic assessment of GERD using the “Los Angeles” classification", Gastrointest Endosc, 49, pp.700~704 (1999)
  46. Tutuian R, "Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance", Aliment Pharmacol Ther, 24(Suppl 2), pp.27~37 (2006)
  47. Tutuian R, "Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring", J Clin Gastroenterol, 37, pp.206~215 (2003)
  48. Kim BJ, "Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain", J Gastroenterol Hepatol, 25, pp.1855~1860 (2010)
  49. Rhee PL, "Treatment of noncardiac chest pain", J Gastroenterol Hepatol, 20(Suppl), pp.S18~S19 (2005)
  50. Achem SR, "Treatment of non-cardiac chest pain", Dis Mon, 54, pp.642~670 (2008)
  51. Caro JJ, "Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials", Clin Ther, 23, pp.998~1017 (2001)
  52. Dekel R, "The role of proton pump inhibitors in gastro-oesophageal reflux disease", Drugs, 64, pp.277~295 (2004)
  53. Vigneri S, "A comparison of five maintenance therapies for reflux esophagitis", N Engl J Med, 333, pp.1106~1110 (1995)
  54. Chiba N, "Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis", Gastroenterology, 112, pp.1798~1810 (1997)
  55. Richter JE, "Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease", Arch Intern Med, 160, pp.1803~1809 (2000)
  56. Fujiwara Y, "Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease", Aliment Pharmacol Ther, 21(Suppl 2), pp.10~18 (2005)
  57. Dean BB, "Effectiveness of proton pump inhibitors in nonerosive reflux disease", Clin Gastroenterol Hepatol, 2, pp.656~664 (2004)
  58. Klinkenberg-Knol EC, "Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa", Gastroenterology, 118, pp.661~669 (2000)
  59. Sarkar S, "Contribution of central sensitisation to the development of non-cardiac chest pain", Lancet, 356, pp.1154~1159 (2000)
  60. Rao SS, "Theophylline improves esophageal chest pain: a randomized, placebo-controlled study", Am J Gastroenterol, 102, pp.930~938 (2007)
  61. Lee H, "Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial", Am J Gastroenterol, 105, pp.1504~1512 (2010)

관련 논문AI추천

한국의 비심인성 흉통의 진단 및 치료의 고유한 특징김정환대한내과학회 · 대한내과학회지2011 · 제80권 제6호관상동맥조영술이 정상인 비심인성 흉통 환자의 상부위장관내시경 소견김남인, 김성환, 박영숙, 송은주, 유승기, 이명하, 전대원, 정준영, 조용범, 조윤주, 최재웅대한내과학회 · 대한내과학회지2009 · 제77권 제2호비미란성 위식도역류질환에서 비심인성 흉통의 임상적 특징과 치료 반응김나영, 박영수, 이동호, 이병환, 정유정, 최태혁, 황태준대한내과학회 · 대한내과학회지2010 · 제79권 제1호비화음으로 호전된 비미란성 역류질환(Non-erosive Reflux Disease) 환자의 비심인성 흉통(Non-cardiac chest pain) 치험 1례고석재, 김금지, 박재우, 전혜진, 조민지대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제6호The Incidence of Gastro-Esophageal Disease for the Patients with Typical Chest Pain and a Normal Coronary Angiogram김권배, 김기식, 김윤년, 남창욱, 이상훈, 이영수, 장병국, 한성욱, 허승호대한내과학회 · The Korean Journal of Internal Medicine2006 · 제21권 제2호기능성 소화불량증의 임상 진료 지침 개정안 2020강승주, 권중구, 김성은, 김준성, 박종규, 방기배, 백명기, 송경호, 신정은, 신철민, 오정환, 이주엽, 임현철, 정경원, 정혜경, 태정현, 대한소화기기능성질환･운동학회 기능성 소화불량증위원회⋅진료지침위원회대한내과학회 · 대한내과학회지2021 · 제96권 제2호

이 간행물의 다른 논문 (21건)

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in ObesityAkila De Silva, Stephen R. Bloompp. 10-20Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric CarcinogenesisM. Blanca Piazuelo, Pelayo Correapp. 21-28The Biology of Cancer Stem Cells and Its Clinical Implication in Hepatocellular Carcinoma윤승규pp. 29-40Effi cacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot StudyNuriye Ulu, Ayşe Oya Övünç Kurdaş, Fatih Güzelbulut, Züleyha Akkan Çetinkaya, Atakan Yeşil, Mesut Sezikli, Mustafa Erhan Altınözpp. 41-44The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma남순우, 이승우, Young Yong Ahn, 강상범, 김연수, 김진만, 이동수, 정현용pp. 45-51
원문 보기